Followers | 9 |
Posts | 1117 |
Boards Moderated | 0 |
Alias Born | 03/20/2022 |
Sunday, January 14, 2024 9:18:22 AM
As with virtually every Biotech, whether well funded or not, it all hinges on the product being effective.
In case everyone hasn't realized as of yet, this space has, for some time now, reverted to the snail pace (for most that is) that it previously operated under, and by that I mean a ""rigid"" clinical process (again, for most, not all).
This means the wait could be long BUT very profitable IMO for those who held.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM